Browse Pet Safety Reports
16,682 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,682 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,682 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Aug 14, 2022 | Human | Unknown | Oclacitinib Maleate | Impaired vision; Conjunctivitis; Eye haemorrhage; Hyperaemic mucous membrane;... | Ongoing |
| Aug 12, 2022 | Human | Unknown | Tilmicosin | Light headedness | Outcome Unknown |
| Aug 12, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Closure, Abnormal; Accidental exposure | Outcome Unknown |
| Aug 11, 2022 | Human | Unknown | Tigilanol Tiglate | Eye irritation; Eye stinging | Recovered/Normal |
| Aug 11, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site irritation; Application site tingling | Outcome Unknown |
| Aug 11, 2022 | Human | Unknown | Phytosphingosine Salicyloyl; Chlorhex... | Application site rash | Recovered/Normal |
| Aug 9, 2022 | Human | Unknown | Amprolium | No sign; Accidental exposure | Recovered/Normal |
| Aug 9, 2022 | Human | Unknown | Dinoprost Tromethamine | Nausea; Injection site pain; Accidental exposure | Outcome Unknown |
| Aug 8, 2022 | Human | Unknown | Buprenorphine | Burning sensation (skin); Rash | Outcome Unknown |
| Aug 8, 2022 | Human | Unknown | Praziquantel | Burning sensation of eye; Burning sensation (skin) | Recovered/Normal |
| Aug 8, 2022 | Human | Unknown | Praziquantel | Stinging sensation in eye | Outcome Unknown |
| Aug 8, 2022 | Human | Unknown | Gamithromycin | Burning sensation of eye; Accidental exposure | Recovered/Normal |
| Aug 6, 2022 | Human | Unknown | Afoxolaner | Diarrhoea; Nausea; Accidental exposure | Recovered/Normal |
| Aug 5, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Ongoing |
| Aug 4, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Ongoing |
| Aug 3, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Accidental exposure | Recovered/Normal |
| Aug 3, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Stomach upset | Ongoing |
| Aug 3, 2022 | Human | Unknown | Buprenorphine | Light headedness | Ongoing |
| Aug 3, 2022 | Human | Unknown | Selamectin;Sarolaner | Headache; Localised pain NOS (see other 'SOCs' for specific pain) | Ongoing |
| Aug 3, 2022 | Human | Unknown | Buprenorphine | Confused | Recovered/Normal |
| Aug 2, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site numbness; Application site tingling | Outcome Unknown |
| Aug 2, 2022 | Human | Unknown | Enrofloxacin | Injection site pain; Injection site bleeding; Accidental exposure | Outcome Unknown |
| Aug 2, 2022 | Human | Unknown | Triamcinolone Acetonide | Application site hair loss; Accidental exposure | Outcome Unknown |
| Aug 1, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Medication error; Accidental exposure; Wrong tec... | Recovered/Normal |
| Jul 31, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Recovered/Normal |
| Jul 30, 2022 | Human | Unknown | Florfenicol; Mometasone Furoate; Terb... | Eye disorder NOS (for photophobia see 'neurological') | Outcome Unknown |
| Jul 30, 2022 | Human | Unknown | Selamectin;Sarolaner | No sign; Tubes, Damaged; Tubes, Leaking; Caps, Abnormal | Recovered/Normal |
| Jul 29, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness; Medication error | Outcome Unknown |
| Jul 28, 2022 | Human | Unknown | Buprenorphine | Nausea | Recovered/Normal |
| Jul 28, 2022 | Human | Unknown | Copper Naphthenate | Localised numbness (see also application site SOC); Stomach cramp; Burning mo... | Ongoing |
| Jul 27, 2022 | Human | Unknown | Altrenogest Oily Solution | Abdominal cramp; Menstruation irregular | Ongoing |
| Jul 27, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness | Recovered/Normal |
| Jul 26, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Recovered/Normal |
| Jul 25, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness; Containers, Leaking; Difficulty of Use | Recovered/Normal |
| Jul 25, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Accidental exposure | Recovered/Normal |
| Jul 22, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Containers, Leaking; Dispenser, Abnormal | Recovered/Normal |
| Jul 22, 2022 | Human | Unknown | Estradiol; Trenbolone | Injection site pain; Injection site swelling | Ongoing |
| Jul 21, 2022 | Human | Unknown | Selamectin;Sarolaner | Localised skin reaction | Outcome Unknown |
| Jul 21, 2022 | Human | Unknown | Spinosad; Milbemycin Oxime | Digestive tract disorder NOS; Drug administration error; Nausea | Recovered/Normal |
| Jul 20, 2022 | Human | Unknown | Narasin; Nicarbazin | Unclassifiable adverse event | Recovered/Normal |
| Jul 18, 2022 | Human | Unknown | Tilmicosin | Heart pounding; Nausea; Chest tightness; Injection site self trauma | Ongoing |
| Jul 18, 2022 | Human | Unknown | Altrenogest Oily Solution | Excessive sweating; Nausea; Gagging; Disorders of menstrual cycle NOS; Accide... | Ongoing |
| Jul 17, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness | Recovered/Normal |
| Jul 15, 2022 | Human | Unknown | Phytosphingosine Salicyloyl; Pramoxin... | Urticaria | Recovered/Normal |
| Jul 14, 2022 | Human | Unknown | Moxidectin | Puncture wound; Accidental exposure | Ongoing |
| Jul 13, 2022 | Human | Unknown | Tulathromycin | Eye irritation; Eye pain; Accidental exposure; Ocular burn | Ongoing |
| Jul 13, 2022 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Stinging sensation in eye; Accidental exposure | Recovered/Normal |
| Jul 13, 2022 | Human | Unknown | Sarolaner | Skin irritation; Taste salty; Swollen mouth | Outcome Unknown |
| Jul 12, 2022 | Human | Unknown | Nitenpyram | Vomiting; Accidental exposure | Outcome Unknown |
| Jul 12, 2022 | Human | Unknown | Moxidectin | Injection site bleeding | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.